The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years

The impact of COVID-19 on population health is recognised as being substantial, yet few studies have attempted to quantify to what extent infection causes mild or moderate symptoms only, requires hospital and/or ICU admission, results in prolonged and chronic illness, or leads to premature death. We aimed to quantify the total disease burden of acute COVID-19 in the Netherlands in 2020 using the disability-adjusted life-years (DALY) measure, and to investigate how burden varies between age-groups and occupations. Using standard methods and diverse data sources (mandatory notifications, populat... Mehr ...

Verfasser: McDonald, Scott A
Lagerweij, Giske R
de Boer, Pieter
de Melker, Hester E
Pijnacker, Roan
Mughini Gras, Lapo
Kretzschmar, Mirjam E
den Hartog, Gerco
van Gageldonk-Lafeber, Arianne B
van den F, Susan
Wallinga, Jacco
RIVM COVID-19 surveillance, epidemiology team
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Schlagwörter: COVID-19 / Cost of Illness / Disability-Adjusted Life Years / Disability-adjusted life-years / Disabled Persons / Disease burden / Humans / Middle Aged / Netherlands / Netherlands/epidemiology / Pandemic / Quality-Adjusted Life Years / SARS-CoV-2 / Seroepidemiologic Studies / Journal Article
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27612808
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dspace.library.uu.nl/handle/1874/446944

The impact of COVID-19 on population health is recognised as being substantial, yet few studies have attempted to quantify to what extent infection causes mild or moderate symptoms only, requires hospital and/or ICU admission, results in prolonged and chronic illness, or leads to premature death. We aimed to quantify the total disease burden of acute COVID-19 in the Netherlands in 2020 using the disability-adjusted life-years (DALY) measure, and to investigate how burden varies between age-groups and occupations. Using standard methods and diverse data sources (mandatory notifications, population-level seroprevalence, hospital and ICU admissions, registered COVID-19 deaths, and the literature), we estimated years of life lost (YLL), years lived with disability, DALY and DALY per 100,000 population due to COVID-19, excluding post-acute sequelae, stratified by 5-year age-group and occupation category. The total disease burden due to acute COVID-19 was 286,100 (95% CI: 281,700-290,500) DALY, and the per-capita burden was 1640 (95% CI: 1620-1670) DALY/100,000, of which 99.4% consisted of YLL. The per-capita burden increased steeply with age, starting from 60 to 64 years, with relatively little burden estimated for persons under 50 years old. SARS-CoV-2 infection and associated premature mortality was responsible for a considerable direct health burden in the Netherlands, despite extensive public health measures. DALY were much higher than for other high-burden infectious diseases, but lower than estimated for coronary heart disease. These findings are valuable for informing public health decision-makers regarding the expected COVID-19 health burden among population subgroups, and the possible gains from targeted preventative interventions.